GAC0003A4
GAC0003A4 is an LXR inverse agonist that inhibits LXR transcriptional activity. GAC0003A4 also efficiently degrades LXRβ protein. GAC0003A4 has the potential to be used in advanced pancreatic cancer and other refractory malignancies[1].
Product Specifications
CAS Number
929492-71-7
UNSPSC
12352005
Target
LXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gac0003a4.html
Purity
98.94
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N1CCN(CC1)C2=C(C)C=CC=C2)C3=CC(OC)=CC(OC)=C3
Molecular Formula
C20H24N2O3
Molecular Weight
340.42
References & Citations
[1]Karaboga H, et al. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity. ACS Chem Biol. 2020 Nov 20;15 (11) :2916-2928.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx110461-01 20 µg
Nitric Oxide Synthase, Endothelial (NOS3) Antibody
Sign In for Pricing
View Details abx110461-02 50 µg
Nitric Oxide Synthase, Endothelial (NOS3) Antibody
Sign In for Pricing
View Details abx110461-03 100 µg
Nitric Oxide Synthase, Endothelial (NOS3) Antibody
Sign In for Pricing
View Details abx110461-04 200 µg
Nitric Oxide Synthase, Endothelial (NOS3) Antibody
Sign In for Pricing
View Details abx110461-05 1 mg
Nitric Oxide Synthase, Endothelial (NOS3) Antibody
Sign In for Pricing
View Details 